AUTOINMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA E IGG
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BIO-RAD, S.A.·Registered March 15, 2019EL BIO-RAD AUTOIMMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA E IGG TEST ES UN ENZIMOINMUNOANÁLISIS EN FASE SÓLIDA (ELISA) QUE EMPLEA MANANO PURIFICADO PARA LA DETECCIÓN SEMICUANTITATIVA Y CUALITATIVA DE ANTICUERPOS IGA E IGG ANTI-SACCHARO
THE BIO-RAD AUTOIMMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA AND IGG TEST IS A SOLID PHASE ENZYME IMMUNOASSAY (ELISA) THAT USES PURIFIED MANNAN FOR THE SEMI-QUANTITATIVE AND QUALITATIVE DETECTION OF IGA AND IGG ANTI-SACCHARO ANTIBODIES
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- INMUNOENSAYO PARA LA DETERMINACIÓN DE IGA E IGG ASCA.
- Trade Name (English)
- IMMUNOASSAY FOR THE DETERMINATION OF IGA AND IGG ASCA.
- Analysis ID
- 554R2019 SSA
- Registration Date
- March 15, 2019
- Name (Spanish)
- BIO-RAD, S.A.
- Name (English)
- BIO-RAD, S.A.
Access comprehensive regulatory information for AUTOINMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA E IGG (AUTOINMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA E IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 554R2019 SSA and manufactured by BIO-RAD, S.A.. The device was registered on March 15, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.